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Gold nanoparticles (AuNPs) impair LPS-driven
immune responses by promoting a tolerogenic-
like dendritic cell phenotype with altered
endosomal structures†
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Dendritic cells (DCs) shape immune responses by influencing T-cell activation. Thus, they are considered both
an interesting model for studying nano-immune interactions and a promising target for nano-based bio-
medical applications. However, the accentuated ability of nanoparticles (NPs) to interact with biomolecules
may have an impact on DC function that poses an unexpected risk of unbalanced immune reactions. Here,
we investigated the potential effects of gold nanoparticles (AuNPs) on DC function and the consequences for
effector and memory T-cell responses in the presence of the microbial inflammatory stimulus lipopolysac-
charide (LPS). Overall, we found that, in the absence of LPS, none of the tested NPs induced a DC response.
However, whereas 4-, 8-, and 11 nm AuNPs did not modulate LPS-dependent immune responses, 26 nm
AuNPs shifted the phenotype of LPS-activated DCs toward a tolerogenic state, characterized by downregula-
tion of CD86, IL-12 and IL-27, upregulation of ILT3, and induction of class E compartments. Moreover, this DC
phenotype was less proficient in promoting Th1 activation and central memory T-cell proliferation. Taken
together, these findings support the perception that AuNPs are safe under homeostatic conditions; however,
particular care should be taken in patients experiencing a current infection or disorders of the immune system.
1. Introduction
The human immune system can be divided in two branches:
the innate and the adaptive immune system. The innate
immune system represents the first line of defense against
pathogens, damaged cells and non-self-objects (e.g. nano-
particles and microbes) and is characterized by a quick and con-
served set of responses carried out by innate immune cells.1
Innate immune responses are usually followed by activation
of the adaptive immune system, which is capable of mounting
a pathogen-specific response mediated by T cells and B cells.
Antigen presenting cells (APCs) act at the interface between
the innate and the adaptive immune systems, with dendritic
cells (DCs) being considered the most important type of APC.
APCs are usually located within tissues and are equipped with a
broad spectrum of receptors which enables them to sense the
presence of pathogens by recognizing conserved molecular pat-
terns on their surface.2,3 One of these patterns is the endotoxin
lipopolysaccharide (LPS), located on the outer membrane of
Gram-negative bacteria and recognized by a receptor complex
composed of Toll-like receptor 4 (TLR4), MD2 and CD14 on the
DC surface.4 Upon pathogen recognition, DCs become activated
and begin a maturation process characterized by the upregula-
tion of co-stimulatory surface molecules, including CD86 and
HLA-DR, and the release of specific cytokines. This maturation
process enables the DCs to activate naïve T cells, thereby initiat-
ing adaptive immune responses. Based on signals provided by
DCs (e.g. cytokines and surface receptors) during the DC–T-cell
interaction, naïve T cells can polarize into pathogen-specific T
helper (Th) cell subsets, which are responsible for coordinating
the elimination of the invading pathogen. Among the different
Th cell subsets, Th1 cells have the task of eliminating intracellu-
lar bacteria and viruses, whereas Th2 cells protect the body
against extracellular parasites. Th17 cells orchestrate the fight
against extracellular bacteria or fungi, while regulatory T cells
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(Tregs) have the crucial role of suppressing excessive inflam-
mation and autoimmunity.5–11 However, unbalanced Th cell
polarization and activation is often linked to immune-related
pathologies.12,13 Interestingly, each of these Th cell subsets, also
known as effector T cells, can be identified using specific mole-
cular markers such as cytokines and surface markers.11 While
many effector T cells die during pathogen clearance, a specific
Th cell population termed “memory cells” remains poised for
years and decades and is crucial for establishing long-term
protection.14,15
Because of their central role in shaping immune responses,
DCs are considered an important model to investigate poten-
tial immunomodulatory properties of nanoparticles (NPs).
Upon interaction of NPs with biomolecules, a biomolecular
corona is formed, which has a significant influence on the fate
and effects of NPs in tissues and cells.16–19 The interactions
between NPs and cells can be intentionally exploited in
medical applications, like cancer treatment or diagnosis;20,21
however, unintended interactions can have undesired effects.
In this context, gold nanoparticles (AuNPs) have attracted
particular attention due to their stability, biocompatibility, and
interesting optical properties, which make them not only suit-
able for different applications in biomedicine, but also a
widely used “model particle” for studying the molecular basis
of nano-immune interactions.21,22
Therefore, the aim of this work was to study the potential
effects of AuNPs on the ability of DCs to promote effector and
memory T-cell activation and proliferation during LPS-induced
immune responses.
To achieve this goal, we first investigated the potential
immunomodulatory properties of endotoxin free-AuNPs of
different sizes (4, 8, 11 and 26 nm) in terms of cytokine
secretion (IL-12, IL-27) and surface marker expression (CD86,
HLA-DR, ILT3) in LPS-treated human monocyte-derived DCs
(moDCs). Next, we analyzed AuNP-induced ultrastructure and
morphological changes, which are of special interest because
internalized NPs may affect the endosomal machinery of
mature DCs known as “endosomal sorting system required for
transport (ESCRT)”, which is involved in several processes rele-
vant for cell-mediated immune responses.23–25
Subsequently, to investigate whether the identified changes
in DC phenotype can alter T-cell polarization, we performed
co-culture experiments of AuNP-treated, LPS-stimulated DCs
with CD4+ Th cells and evaluated the production of Th1 cell-
specific cytokines.
Finally, to study the effects of NPs in a more complex
model, we incubated human peripheral blood mononuclear
cells (PBMCs) with AuNPs and/or LPS and assessed both
effector and memory T-cell responses using an advanced
13-color flow cytometry panel.
2. Experimental section
2.1 AuNP synthesis
Sodium citrate-stabilized gold nanoparticles (AuNPs) were syn-
thesized using two kinetically controlled seeded growth
methods as described by Bastús et al.26 and by Piella et al. (for
the 4 nm particles)27 using tetrachloroauric(III) acid trihydrate
(99.9% purity) and sodium citrate tribasic dihydrate (≥99%)
(SC) purchased from Sigma-Aldrich.
Since innate immune cells are extremely sensitive to endo-
toxin contamination, we applied an “LPS-free” synthesis proto-
col to prevent unspecific cell activation in our experiments.
Briefly, the reagent solutions for the synthesis were prepared
with endotoxin-free material and with LPS-free water (Cape
Cod Incorporated) under a flow hood. Disposable plastic
materials and syringe needles were purchased LPS-free (B.
Braun), lab glassware was wrapped with aluminum foil and
depyrogenated in a lab oven at 200 °C overnight, and rubber
stoppers and stir bars were cleaned with ethanol and left to
dry in the flow hood. To quantify potential residual LPS con-
tamination, we performed both an NF-κB-luc reporter gene
assay and an EndoLISA assay.
2.2 AuNP physicochemical characterization
NP post-synthesis characterization and analysis of protein
corona formation in relevant culture medium were performed
using four different techniques. The use of such techniques
for NP characterization was shown to be reliable in previous
studies.26,27
Electron microscopy. Size and shape of the AuNPs were
assessed via Scanning Electron Microscopy using an FEI
Magellan XHR SEM in transmission mode (STEM) operated at
20 kV and an FEI Tecnai G2 F20 S-TWIN HR(S)TEM operated
at an accelerated voltage of 200 kV. After synthesis, 2 μL of the
sample were drop-casted on a carbon-coated copper TEM grid
and dried at room temperature (RT) using a vacuum drier. To
avoid handling-dependent aggregation during sample prepa-
ration, AuNPs were functionalized by adding 11-mercaptoun-
decanoic acid (MUA) (Sigma-Aldrich) at a final concentration
of 0.1 mM. The solution was then left for 2 h at RT under slow-
stirring conditions; subsequently, NPs were purified from the
MUA excess by centrifugation. After image collection, particles
were analyzed using ImageJ to obtain reliable size-distribution
data.
UV-vis spectroscopy. A Shimadzu UV-2400 spectrophoto-
meter was used to acquire the UV-vis spectra. Spectral acqui-
sition was performed at RT in the 300–750 nm range using dis-
posable plastic cuvettes. MilliQ water and complete culture
medium were used as a reference.
Size and zeta potential measurements. The hydrodynamic
diameter and Z potential of AuNPs both in SC and after incu-
bation in moDC medium were assessed at 37 °C using a
Malvern Zetasizer Nano ZS by Dynamic Light Scattering (DLS),
and Laser Doppler Velocimetry (LDV). Diameters were reported
as a distribution by intensity calculated by non-negative least
squares (NNLS) analysis. Z potential is not an intrinsic value
but depends on the conductivity of the solution in which NPs
are dispersed. Consequently, to compare the Z potential of
different samples, their conductivity has to be similar. Thus,
after exposure to the medium the AuNPs were purified by cen-
trifugation and resuspended in SC (2.2 mM) to obtain a final
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conductivity similar to that of the pristine AuNPs (about
0.7 mS cm−1).
AuNP behavior in culture medium. To evaluate the stability
of our NPs in moDC medium and to assess the formation of
the protein corona, we incubated the particles for 1, 24 and
48 h, 5 × 1011 AuNPs per well with 900 μL of complete culture
medium [moDC medium: RPMI-1640 (Sigma) supplemented
with 10% heat-inactivated (i.a.) pure fetal bovine serum
(FBS) (PAA) (Thermo-Fisher), 2 mM L-glutamine (Sigma),
100 U mL−1, penicillin/streptomycin (Sigma), 50 μM
β-mercaptoethanol (Gibco Laboratories)]. Differences in
volume between the AuNP batches were compensated by the
addition of LPS-free SC 2.2 mM up to a final volume of 1.2 mL.
Since the absorption spectrum generated by the pH-sensing
molecule phenol red is comparable to the one obtained for
AuNPs, we used a phenol red-free RPMI [RPMI-1640 R7509].
Sodium citrate, moDC medium and AuNPs in SC were used as
controls.
2.3 Cell culture conditions
All cells were cultured at 37 °C, 5% CO2 and 95% humidity. The
incubation time of nanoparticles and cells was estimated on the
basis of the findings of Casals et al.,28 who showed that protein
corona formation reaches a stability point (hard corona) after
approximately 48 h of incubation in culture medium.
In order to exclude potential side effects of endotoxin con-
tamination in AuNPs, we used a concentration of AuNPs which
was insufficient to activate immune cells. This concentration
was calculated on the basis of the endotoxin content measured
by the EndoLISA assay. Since every batch possessed different
levels of contamination, we used the highest possible amount
of 26 nm AuNPs as a reference (5 × 1011 NPs per well) and
equalized the concentration of the other batches in terms of
particle number. Because of the different sizes of the used
AuNPs, maintaining the number of particles applied on cells
simultaneously increased the amounts of gold and surface
area in a way that is directly proportional to the particle dia-
meter. Detailed information on corresponding concentrations
of NPs in terms of µg mL−1 or surface area per µL can be calcu-
lated using Table 1 assuming a 100% spherical shape. Since
the synthetic method used in this paper generates particles
that are more and more diluted after every growing step, in
order to apply 5 × 1011 NPs per well we added different
volumes of AuNP stock solution. The different volumes were
then equalized by the addition of SC 2.2 mM, which is used as
a stabilizer during the NP synthesis. LPS concentration was
based on previous studies.29
2.4 Quantification of LPS-contamination
Two different methods were used to detect LPS contamination.
EndoLISA (Hyglos Gmbh). EndoLISA was used for quantitat-
ive determination of endotoxin contamination of AuNP prep-
arations, according to the manufacturer’s recommendations.
Samples were diluted 1 : 2 in LPS-free water and the binding
step was carried out for 18 h. Acquisition was performed on a
microplate reader (Tecan Infinite M200Pro) with a fixed gain
of 100. Analysis was performed using a 4-Parameters Logistic
Regression Model. LPS contamination was then expressed in
EU mL−1 (EU, endotoxin units).
NF-κB-luc TLR4 reporter gene assay. As described by Schwarz
et al.,30 HEK293 cells (mycoplasma negative, culture passage
5–15) were seeded in DMEM [DMEM (Sigma-Aldrich) sup-
plemented with 10% FBS, 2 mM MEM non-essential amino
acids (PAA) (Sigma-Aldrich), 2 mM L-glutamine, 100 U mL−1
penicillin/streptomycin] at a final concentration of 1.5 × 105
cells per mL and incubated for 24 h. On day 2, cells were trans-
fected with both a reporter plasmid containing the NF-κB tran-
scription factor linked to a luciferase reporter gene, and a mix
of 3 plasmids (TLR4, MD2 and CD14) encoding the LPS receptor
components. After 24 h, supernatants were discarded and sub-
stituted with 900 µL of fresh medium. Cells were then stimu-
lated by the addition of LPS 30 pg mL−1 (E. coli lipopolysacchar-
ide (LPS) 055:B5 (Sigma-Aldrich)), AuNPs of different sizes (5 ×
1011 NPs per well), LPS plus AuNPs, or left untreated. Volume
differences were compensated by adding PBS to a final volume
of 1.2 mL. On day 4, supernatants were discarded, cells were
lysed and lysates were read by a Tecan Infinite M200Pro instru-
ment. To exclude AuNP interference in signal absorbance, data
are expressed in the form of a ratio between LPS or AuNPs +
LPS and the corresponding controls, untreated cells or AuNPs.
Table 1 AuNP post-synthesis characterization
Characteristics Batches
Name 4 8 11 26
Material Au Au Au Au
Stabilizer Sodium citrate Sodium citrate Sodium citrate Sodium citrate
Diameter by STEM [nm] 4.0 ± 0.6 8.8 ± 1.5 11.8 ± 0.8 26.4 ± 3.0
Hydrodynamic Diameter [nm] 5.6 ± 1.4 12.8 ± 3.0 15.1 ± 3.7 36.8 ± 14.1
Absorption peak [nm] 504 519 516 523
Z potential [mV] Not detected. −49.3 ± 5.0 −47.0 ± 5.0 −35.6 ± 0.6
Concentration [NPs per ml] 5.0 × 1013 5.0 × 1012 6.0 × 1012 1.7 × 1012
Au concentration [mM] 0.167 0.166 0.500 1.650
Au concentration [mg mL−1] 0.033 0.033 0.100 0.325
Total surface area [nm2 mL−1] 2.5 × 1015 1.2 × 1015 2.6 × 1015 3.8 × 1015
Table summarizing the main characteristics of the batches used in this study.
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2.5 Generation of human monocyte-derived dendritic cells
(moDCs)
PBMCs were isolated from buffy coats of donors by density
gradient centrifugation using histopaque-1077 (Sigma) as
described by Posselt et al.31 The buffy coats used in this
study were kindly provided by the blood bank of Salzburg,
Austria. According to Austrian regulations, no informed
consent is required if blood cells derived from anonymous
healthy donors, discarded after plasmapheresis (buffy coats),
are used. Therefore, no additional approval by the national
ethics committee was required. Monocytes were then purified
from PBMCs using the CD14+ MicroBeads UltraPure human
kit (Miltenyi Biotec) according to the manufacturer’s instruc-
tion. Subsequently, cells were cultured for 6 days in moDC
medium (2.5 × 105 cells per mL, supplemented with 50 ng
mL−1 GM-CSF and 50 ng mL−1 IL-4 (a generous gift from
Novartis)). After 48 h, monocytes were fed 1 vol. medium
containing fresh IL-4 and GM-CSF at a final concentration of
50 ng mL−1. To assess the efficacy of the differentiation pro-
tocol, DC and monocyte lineage marker expression and mor-
phology were assessed by both flow cytometry and differen-
tial staining (Diff–Quik; Medion Diagnostics) following Pickl
work.32 Residual CD14− CD1a− cells, most likely polymorpho-
nuclear granulocytes (PMNGs), which can be observed after
monocyte isolation, are characterized by a limited lifespan
and will therefore die during the process of moDC
differentiation.
2.6 Cytotoxicity and viability assessment
1 × 105 moDCs were plated in 900 µL of DC medium and
stimulated for 48 h either with LPS (30 ng mL−1, final concen-
tration), different sizes of AuNPs (5 × 1011 NPs per well) or left
untreated. Volume differences were compensated with sterile-
filtered LPS-free SC 2.2 mM to a final volume of 1.2 mL. To
detect toxicity, two methods were used.
LDH assay (Promega). Cytotoxicity was assessed by quanti-
fication of lactate dehydrogenase (LDH) release in 90 µL of
cell supernatant using a “CytoTox 96® Non-Radioactive
Cytotoxicity assay kit” following the manufacturer’s rec-
ommendations. As a positive control, cells were lysed with
0.10% (v/v) Triton X-100 for 30 min prior to harvesting to
achieve maximum LDH release.
CellTiter-blue (CTB) (Promega). Cell viability was assessed
via CTB assay following the manufacturer’s instructions. After
1 h of incubation, supernatants were analyzed. Cells treated
with Triton X-100 served as a control for low viability. A micro-
plate reader (Tecan Infinite M200Pro) was used to record
sample absorbance (LDH) and fluorescence emission (CTB)
following the manufacturer’s instructions.
2.7 Impact of AuNPs on LPS-stimulated moDCs
To assess the potential impact of AuNPs of different sizes on
LPS-induced immune responses, 1 × 105 DCs were plated in
900 µL of DC medium and stimulated for 48 h either with LPS
(30 ng mL−1, final concentration), AuNPs alone (5 × 1011 NPs
per well), LPS plus AuNPs, or left untreated. The NP dose (5 ×
1011 NPs per well) was chosen because it is the highest concen-
tration that can be added without inducing cell activation by
LPS contamination and without diluting the cell culture
medium to an extent that could result in reduced cell viability
and NP aggregation.
Volume differences were compensated with SC 2.2 mM up
to a final volume of 1.2 mL. After 48 h, supernatants were col-
lected and tested for IL-6, IL-8/CXCL8, IL-12, TNF-α
(Peprotech) and IL-27 (R&D) release by ELISA. Cell surface
markers and cell structures were analyzed via flow cytometry
or TEM.
2.8 CD4+ T-cell isolation and co-culture with moDCs
DCs were stimulated as described before. Briefly, 0.25 × 105
DCs per well were cultured for 48 h in 225 µL of moDC
medium supplemented with the previously stated stimuli in a
48-well plate (LPS 30 ng mL−1 final concentration, AuNPs 1.25
× 1011 NPs per well, LPS + AuNPs). Untreated cells served as a
negative control. Again, volume differences were compensated
with SC up to a final volume of 300 µL. After 48 h, allogeneic
CD4+ T cells were isolated from buffy coats using a Human
CD4+ T cell Isolation Kit from Miltenyi Biotec, added to
moDCs at a ratio of 10 : 1 in 300 µL of moDC medium sup-
plemented with IL-2 (100 U mL−1) and co-cultured for 6 days.
After 72 h, IL-2 50 U mL−1 was added to each well to promote
T-cell survival. On day 6, supernatants were harvested and
tested for cytokine release by ELISA (Peprotech) and
LEGENDplex.
2.9 Generation and culture of human PBMCs
PBMCs were isolated from buffy coats as described in section
2.5 and seeded in a 24-well plate at a concentration of 1 × 106
in 900 µL, and stimulated for 6 days either with LPS (30 ng
mL−1, final concentration), AuNPs of 4-, 8-, 11- and 26 nm (5
× 1011 NPs per well), LPS plus AuNPs, or left untreated. The
final volume was then equalized by the addition of SC 2.2 mM
up to a final volume of 1.2 mL. Subsequently, supernatants
were harvested and analyzed via ELISA (R&D), while cells were
stained and analyzed using a 13-color flow cytometry panel.
The number of cells used in this experiment was calculated
based on the composition of PBMCs in healthy individuals,
which presents an average amount of APCs (monocytes plus
DCs) ranging between 11% and 22% of the total population.
By using 1 × 106 cells per well, we guaranteed the presence of
at least 1 × 105 APCs in the preparation, which is in line
with the experiments performed with DCs (see sections 2.6
and 2.7).33
2.10 Flow cytometry
Surface marker expression on DCs was assessed via flow cyto-
metry by staining the cells with α-HLA-DR APC, Fixable
Viability Dye eFluor506, α-CD1a BV421, α-CD86 PE
(eBioscience), α-CD14 PerCP-Cy5.5 (BD Bioscience) and α-ILT3
PerCP-Cy5.5 (Biolegend). Samples were subsequently acquired
using a FACS Canto II flow cytometer (BD Biosciences). The
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shown MFI data were collected after exclusion of doublets and
dead cells.
Surface marker expression on PBMCs was assessed via flow
cytometry using a 13-color flow-cytometry panel generated by
using the Optimized Multicolor Immunofluorescence Panel-
030 (OMIP-030)34 as a reference: CD4 BV510, CD127
AlexaFluor 700, CD8a PE-Cy5, CD3 PerCP-Cy5.5, CD45RA
BV605, CD25 PE, CD20 APC-Cy7, CD194 PE-Cy7, CD197 PE/
Dazzle594 (Biolegend), CCR10 APC (BD Biosciences), Ki-67
BV650, CD196 BB151, CD183 BV421 (BD Horizon) Fixable
Viability Dye APC-Cy7 (eBioscience). Samples were acquired
using a Cytoflex S flow cytometer (Beckman Coulter) and then
analyzed using the gating strategy summarized in ESI Fig. 5.†
2.11 LEGENDplex™
Supernatants were centrifuged in 96-well V-bottom plates for
10 min at 1000 g to eliminate NPs which might interfere with
the assay. The release of cytokines was assessed using the
LEGENDplex™ Human Th Panel (13-plex) (Biolegend) kit,
according to the manufacturer’s recommendations. Sample
acquisition was performed using a Cytoflex S flow cytometer
(Beckman Coulter), and LEGENDplex v8.0 Analyst Software was
used for data evaluation.
2.12 Transmission electron microscopic (TEM) preparation
of DCs
After stimulation, moDCs were transferred into sample
holders for subsequent high-pressure freeze fixation (HPF).
HPF was carried out in a Leica Empact HPF device (Leica
Microsystems), with a cooling rate of approximately 12 000 °C
s−1 and a pressure value of at least 2040 bar. The cryo-substi-
tution was transacted with a Leica EM AFS (Leica
Microsystems) at defined cycles.35 The substitution medium
contained 2% osmium tetroxide (OsO4) and 0.05% uranyl
acetate in anhydrous acetone. After the cryo-substitution, the
samples were washed three times with anhydrous acetone and
propylene oxide and were then embedded into epoxy resin
(medium grade; Agar Scientific). The embedding of samples
was carried out in Beem® capsules (Agar Scientific) to ensure
that moDC samples would sink and gather at the narrow
bottom of the capsules for further preparation. Afterwards,
samples were polymerized at +70 °C for 24 h. Ultra-thin sec-
tioning (∼70 nm) was performed with a Leica UC7
Ultramicrotome (Leica Microsystems) and sections were col-
lected on Formvar-coated copper grids. TEM preparation was
conducted as in previous studies and adapted for DCs.35,36
2.13 Transmission electron microscopic (TEM) imaging
of DCs
TEM imaging of DCs was carried out by using a LEO 912 AB
TEM with an in-column Omega energy filter (Zeiss) at 80 kV
accelerating voltage. TEM images were recorded with a Tröndle
TRS Sharp Eye bottom-mounted 2 K CCD camera (Tröndle), fil-
tered at zero energy loss. The TEM implementation and
recording process were controlled by iTEM 5.0 software
(Olympus).
2.14 Statistical analysis
Statistical analyses were performed using GraphPad Prism
Software Version 6.01. P values for multiple groups were calcu-
lated via repeated-measures ANOVA with a Tukey’s post-hoc
test. Data are shown as mean + SD. The Geisser-Greenhouse
correction was not applied. P-values < 0.05 were considered
statistically significant (*p < 0.05, **p < 0.01, ***p < 0.001,
****p < 0.0001).
2.15 Reported information about the experiments
The experiments were conducted and reported following
MIRIBEL guidelines.37
3. Results and discussion
3.1 AuNP characterization both after synthesis and in
relevant culture medium
As reported by other authors, the majority of immune
responses to nanomaterials (NMs) are characterized by an
adaptation process resulting in silent elimination of the NM or
transient inflammation followed by full resolution.1 However,
despite being regarded as reasonably safe when administered
in therapeutic doses and under homeostatic conditions, some
NMs may have deleterious effects in cases where there is a less
balanced immune system, e.g. during acute inflammation.
Due to their elevated energy potential, NPs are highly reactive
objects that constantly interact with other molecules in order
to achieve a more stable thermodynamic status. This might
result in the binding and functional alteration of biomolecules
and signaling pathways which play a critical role in defining
the outcome of an immune response, ultimately leading to the
establishment of undesired immunological side effects.17
Therefore, evaluation of immunomodulatory effects of NMs is
crucial to ensure patient safety.
Since the reactivity of NPs is strongly influenced by their
composition, size, charge, shape, and aggregation status, it is
of outmost importance to carry out a comprehensive character-
ization of NMs used in biological studies. In this work in par-
ticular, characterization of our gold nanoparticles was per-
formed both after synthesis and in relevant culture conditions
following MIRIBEL (Minimum Information Reporting in Bio-
Nano Experimental Literature) recommendations.37
To do so, we first generated four different batches of mono-
dispersed citrate-stabilized gold NPs with an average diameter
of 4.0 ± 0.6 nm, 8.8 ± 1.5 nm, 11.8 ± 0.8 nm and 26.4 ± 3.0 nm,
respectively, using two kinetically controlled seeded growth
methods. Then, data regarding their Z potential, absorption
spectra and hydrodynamic diameter after synthesis were
acquired via laser doppler velocimetry (LDV), transmission
electron microscopy (TEM), UV-vis spectroscopy and dynamic
light scattering (DLS) and are summarized in Table 1 and
Fig. 1A. Interestingly, all the physicochemical properties of the
tested nanoparticles were in line with the ones obtained by
Bastús et al.26 and by Piella et al.38 in their work, highlighting
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the quality and reliability of the synthetic method used in this
study.
Subsequently, since NP aggregation is also known to be a
critical factor able to modulate the in vitro response of
immune cells, such as monocytes and DCs, in terms of NP
uptake and cell activation,39 we investigated NP stability and
behavior in biologically relevant culture medium.
To do so, AuNPs were incubated for 1, 24 and 48 h in
moDC medium and analyzed by UV-vis spectroscopy and LDV.
Upon data evaluation, we did not detect profile changes of UV-
vis spectra (e.g. a secondary peak) that would be representative
of NP aggregation. This indicates that the 8-, 11-, and 26 nm
batches were colloidally stable over the tested period under
these conditions. However, the presence of a red-shift in the
UV-vis spectra, which increased over time (reaching stable
values after 24–48 h), suggests the formation of a protein
corona which promotes a change in the local refractive index
on the NP surface (Fig. 1B top). This hypothesis was further
supported by the data acquired via LDV, which show (at 1 h of
incubation) an increase in the Z potential values comparable
to that obtained for FBS (dashed line), suggesting that serum
proteins were effectively adsorbed on the NP surface, masking
the particle’s negative charge (Fig. 1B bottom). Unfortunately,
due to the higher scattering intensity of the serum proteins, it
was not possible to obtain meaningful data for the 4 nm
AuNPs in culture medium.
Taken together, these results suggest that the AuNP batches
used in this study are monodispersed, not aggregated, and
stable under the tested culture conditions. Thus, we can expect
that any potential immunomodulatory effects that these
Fig. 1 AuNP post-synthesis characterization and behavior in culture medium. (A) Representative TEM images of AuNP samples overlaid with both
the corresponding size distribution curve and a photo of the AuNP suspensions; (B) UV-vis absorption spectra (top) and zeta potential values
(bottom) of AuNPs both after synthesis (AS) or incubation in moDC medium for 1, 24, and 48 h. Data are shown as mean + SD. Dashed line in panel
B bottom represents the Z potential of FBS.
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AuNPs exert on human DCs will be due to the activity of single
particles rather than their aggregates.
3.2 AuNP characterization via cell-based assays: cytotoxicity
and LPS contamination
LPS is an important component of the bacterial cell wall and,
due to its great stability and broad distribution on all surfaces,
is frequently encountered as an impurity in pharmaceutical
preparations, orthopedic implants and NPs even in the
absence of viable bacteria.40–42 Because immune cells such as
DCs are extremely sensitive to exceedingly low endotoxin con-
centrations (<20 pg mL−1),41 testing all NP suspensions for the
presence of residual LPS is essential to ensure that possible
effects of NPs on immune cells are triggered by the NPs them-
selves and not by undetected LPS contamination. For this
purpose, we performed a cellular TLR4-NF-κB reporter gene
assay and a non-cellular EndoLISA test.
Non-cellular assays such as the EndoLISA are based on
factors involved in the blood coagulation system of the horse-
shoe crab Limulus polyphemus. These assays take advantage of
a coagulation cascade, starting with the binding of LPS to
Factor C and ending in the activation of a pro-clotting
enzyme.43 However, the reliability of non-cellular assays can be
affected by an “LPS-masking effect” caused by chelators or
detergents, which makes LPS undetectable in Factor C-based
assays.30 Therefore, we additionally applied an NF-κB reporter
gene assay using HEK293 cells transiently transfected with
plasmids encoding a functional LPS receptor together with an
NF-κB-luciferase reporter plasmid.
Using the EndoLISA assay, we analyzed the endotoxin
content in the AuNP stock solutions and found that 8- and
26 nm particles contain a detectable amount of endotoxin, as
indicated in ESI Table 1.† It is well documented that even the
very low LPS concentration of 0.1 EU mL−1 is capable of acti-
vating human immune cells, including DCs.41 Since the aim of
this study is to investigate the effects of AuNPs under inflam-
matory conditions, we calculated the maximum number of
particles for all batches that can be applied to DCs without
inducing an immune response induced by contaminating LPS,
and found this NP-dose to be equal to 5 × 1011 NPs per well
(correspondent to 4.16 × 1011 NPs per mL). In this context,
Fig. 2A top summarizes the estimated endotoxin content in
Fig. 2 AuNP characterization via cell-based assays. Graphs represent (A) assessment of LPS contamination via EndoLISA (top) and via TLR4/NF-κB-
luc reporter gene assay (bottom); here the ratio was calculated between the LPS-containing samples (30 pg mL−1 LPS) and the respective controls
(AuNPs alone or untreated samples). The dashed line in panel A top represents the minimum amount of LPS capable of activating immune cells. The
conversion rate from EU mL−1 to ng mL−1 is 10 : 1. (B) Cytotoxicity assay based on detection of LDH release and resazurin conversion (CTB) per-
formed on moDCs after 48 h of stimulation with the stated stimuli (5 × 1011 NPs per well, 30 ng mL−1 LPS) (two individual experiments, n = 4).
Statistical analysis was performed using repeated-measures ANOVA combined with the Tukey’s post test. ****P < 0.0001. Data are shown as mean +
SD. CTB, CellTiter-Blue, EU, Endotoxin Unit, LDH, lactate dehydrogenase, LPS, lipopolysaccharide, MFI, mean fluorescence intensity, NF-κB, nuclear
factor kappa-light-chain-enhancer of activated B cells, NP, nanoparticle, TLR4, toll-like receptor 4.
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the culture medium after addition of 5 × 1011 NPs per well,
which is below 0.1 EU mL−1 for all AuNP batches used.
To confirm that the endotoxin contamination present in
the chosen dose of particles is indeed unable to activate the
LPS receptor complex composed of TLR4, MD2 and CD14, we
performed an NF-κB-luc reporter gene assay using transiently
transfected HEK293 cells. As shown in Fig. 2A, lower panel,
the TLR4/MD2/CD14-NF-κB reporter gene assay showed that
NF-κB activation is increased in the presence of LPS, both with
or without AuNPs, while none of the tested batches was able to
activate NF-κB when applied alone at the dose of 5 × 1011 NPs
per well (Fig. 2A, bottom). Since HEK293 cells expressing the
LPS receptor complex are as sensitive to LPS as DCs are,41 we
conclude that AuNPs applied at a dose of 5 × 1011 NPs per well
are not sufficient to activate human DCs via their residual
endotoxin contamination. We thus used this NP concentration
for all the following experiments.
The next important step was to quantify, and eventually
exclude, NP-induced toxicity, as this can deeply impair the
ability of DCs to upregulate surface markers and release
soluble mediators, thus possibly masking immunomodulatory
properties of NPs. To this end, we performed both lactate
dehydrogenase (LDH) and CellTiter-Blue (CTB) assays in
moDCs that had been treated with AuNPs for 48 h. The LDH
test measures cell death by quantifying LDH, a cytoplasmic
enzyme released upon cell membrane lysis, whereas CTB pro-
vides information on cellular metabolic activity by assessing
the conversion of the substrate resazurin into resorufin by
viable cells. As shown in Fig. 2B, no significant cytotoxicity to
moDCs was induced by exposing the cells to 5 × 1011 NPs per
well, which further supports the use of this dose in the follow-
ing experiments. Interestingly, these results are in line with
the comprehensive study by Khlebtsov et al.,44 who found that
AuNPs are generally nontoxic when applied at concentrations
lower than 1012 NPs per mL. The high background observed in
the LDH assay can be explained by LDH naturally present in
FBS, which is used as a supplement in the cell culture
medium.45
3.3 26 nm AuNPs decrease the LPS-dependent release of
IL-12 and IL-27 in DCs
Monocyte-derived DCs are a subset of DCs which differentiate
from monocytes in tissues under inflammatory conditions and
play a crucial role in host defense.46 These cells can also be
generated in vitro by culturing monocytes with a cocktail of
polarizing cytokines. Therefore, they are an interesting model
for investigating nano-immune interactions during acute
inflammation.32
To generate moDCs, we first purified human PBMCs from
the blood of healthy donors via density gradient centrifugation
(Fig. 3A). Subsequently, we incubated these cells with beads
coated with anti-CD14 antibodies and extracted a population
of CD14+ monocytes via magnetic cell separation. Monocytes
were then differentiated into moDCs in the presence of IL-4
and GM-CSF for 7 days.31 To confirm the efficiency of the
differentiation protocol, we investigated cell morphology and
surface marker expression by differential staining (Diff-Quik)
and flow cytometry, respectively. In line with previous
studies,32 moDCs were characterized by high expression of
CD1a, the loss of CD14 and the presence of a round nucleus
surrounded by several cytoplasmic projections, and therefore
were considered to be fully differentiated. In contrast, mono-
cytes were found to be CD1a−, CD14high cells with a lobular
nucleus (Fig. 3A).32
To assess if AuNPs have an impact on LPS-induced immune
responses, the obtained moDCs were incubated for 48 h either
with LPS, AuNPs of different sizes (4, 8, 11, and 26 nm), AuNPs
plus LPS or left untreated (Fig. 3B). Upon LPS stimulation, DCs
are known to become activated and secrete several soluble
mediators, which are crucial for Th cell differentiation. As
shown in Fig. 3B and ESI Fig. 1,† and in line with previous
reports,29,41,47,48 the DCs produced high amounts of cytokines
(IL-12, IL-27, IL-6, TNF-α) and chemokines (IL-8/CXCL8) in
response to LPS stimulation. However, when LPS-treated DCs
were co-incubated with 26 nm AuNPs, the secretion of IL-12
and IL-27, which are cytokines involved in promoting the
differentiation of Th1 cells,32,47–50 was significantly reduced
(Fig. 3B). Other cytokines, such as TNF-α, IL-8/CXCL8 and IL-6,
which are not clearly associated with Th1 cell development,
were not significantly affected by the treatment (ESI Fig. 1†).
Interestingly, 4, 8 and 11 nm AuNPs did not impair LPS-depen-
dent DC-activation and none of the tested batches were
capable of inducing the release of cytokines in the absence of
LPS (Fig. 3B and ESI Fig. 1†).
3.4 26 nm AuNPs affect LPS-dependent surface marker
expression in moDCs
Another hallmark of DC maturation is the expression of
surface markers such as CD86, ILT3 and HLA-DR. Like soluble
mediators such as cytokines, these cell-surface proteins play a
crucial role in determining the nature and intensity of an
immune response. Surface molecules facilitate the physical
interaction of DCs and T cells during the process of antigen
presentation, whereby HLA-DR, for example, has the function
of presenting antigenic peptides to antigen-specific naïve T
cells. In combination with signals provided by the costimula-
tory molecule CD86, which is upregulated upon LPS stimu-
lation, T-cell activation can be induced. In contrast, the co-
inhibitory molecule ILT3 counteracts T-cell activation by pro-
viding immunoregulatory signals.51 Therefore, we assessed the
expression of CD86, HLA-DR and ILT3 on moDCs treated with
AuNPs/LPS by using flow cytometry.
In line with previous studies, LPS promoted significant
upregulation of both HLA-DR and CD86 expression on the DC
surface in comparison to untreated control cells (Fig. 4A).29,52
Interestingly, 4, 8, and 11 nm AuNPs did not modulate the DC
response to LPS (Fig. 4A). However, treatment with 26 nm
AuNPs/LPS caused significant downregulation of CD86
(Fig. 4A), accompanied by robust upregulation of ILT3
(Fig. 4B), while HLA-DR remained unchanged. Fig. 4C shows
the relative expression of CD86 and ILT3 on cells of one repre-
sentative donor.
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To exclude that our findings are batch-specific, we repeated
all experiments using a batch of fully characterized 25 nm
AuNPs produced as described for the first batch and obtained
similar results (ESI Table 2 and Fig. 2†).
Taken together, the results described in Section 3.3 and 3.4
demonstrate that 26 nm AuNPs, but not smaller AuNPs, exert
regulatory effects capable of impairing LPS-dependent DC
maturation, potentially affecting the capacity of DCs to
Fig. 3 26 nm AuNPs hamper LPS-induced cytokine secretion in moDCs. (A) Schematic representation of the protocol used. Morphological changes
occurring during the moDC-differentiation process after MACS-purified monocytes have been incubated with GM-CSF and IL-4 are summarized in
the rectangular insets. Monocytes are characterized by a U-shaped nucleus and high CD14 expression, whereas DCs exhibit several cell-protrusions,
high CD1a expression and the loss of CD14 on their surface. Cells were stained with Diff-Quik stain and imaged by optical microscopy. (B) To assess
the influence of AuNPs on LPS-induced cytokine release, moDCs were cultivated for 48 h with the stated stimuli (5 × 1011 NPs per well, 30 ng mL−1
LPS) and subsequently supernatant was collected and analyzed for IL-12 and IL-27 secretion via ELISA. Statistical analysis was performed using
repeated-measures ANOVA combined with Tukey’s post test **P < 0.01; ****P < 0.0001 (4 individual experiments, n ≥ 7). Data are shown as mean +
SD. Significance is shown as indicated. RBC, red blood cell, DC, dendritic cell, LPS, lipopolysaccharide, NP, nanoparticle, PML, polymorphonuclear
leukocyte; PBMC, peripheral blood mononuclear cell.
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promote T-cell activation. Interestingly, AuNPs exerted these
immunomodulatory effects only in the presence of a concomi-
tant microbial stimulus (LPS). The fact that immunomodulat-
ing effects of AuNPs on DCs are rare is well documented in the
literature53–55 and explains why AuNPs are generally con-
sidered to be safe and suitable for biomedical applications. In
the context of ongoing inflammation, however, we found that
our largest AuNPs did hamper DC activation, promoting the
acquisition of a semi-mature phenotype characterized by
reduced expression of the activation marker CD86, diminished
secretion of the pro-inflammatory cytokines IL-12 and IL-27,
and concomitant upregulation of the anti-inflammatory recep-
tor ILT3. This phenotype differs substantially from that com-
monly induced by LPS10 or other bacterial stimuli,56
suggesting that the activation of anti-bacterial Th1 cells, which
are usually generated upon LPS stimulation, and whose differ-
entiation relies on CD86, IL-12 and IL-27 secretion,50,57,58 may
be significantly impaired by the application of 26 nm AuNPs.
A semi-mature phenotype is a typical feature of tolerogenic DC
(tDCs). tDCs, by presenting antigens in the context of reduced
costimulatory capacity (CD86low) and a significantly altered
cytokine profile, can promote tolerance and T-cell anergy,
which are important mechanisms for eliminating alloreactive
T cells and regulating the intensity and duration of inflamma-
tory immune responses.59 In this scenario, ILT3, which is a
characteristic marker of tDCs,60 plays a crucial role in the sup-
pressor capacity of T cells and induces T-cell anergy.61
It is worth noting that, to our knowledge, this is the first
study to report that citrate-stabilized AuNPs can affect IL-27
and ILT3 production. Effects of AuNPs on CD86 and IL-12 were
previously reported by Villiers et al. and Tomić et al., who
observed similar immunomodulatory effects.54,55 However, in
our study, the effects were induced exclusively by 26 nm AuNPs
(and not 10 nm AuNPs). Moreover, we saw no evidence of
effects on HLA-DR expression. This discrepancy might be due
to several factors, including the doses of the stimulants, NP
purity and NP concentrations.
Interestingly, in our study, only factors involved in Th1
polarization (CD86, IL-12, IL-27) were affected by AuNP treat-
ment, while the ability of DCs to express HLA-DR, IL-8/CXCL8,
TNF-α and IL-6 was not impaired. These findings suggest that
DCs may retain their ability to promote antigen presentation
(HLA-DR), neutrophil recruitment (IL-8/CXCL8),62 and Th17
differentiation (IL-6).11
Fig. 4 26 nm AuNPs downregulate LPS-induced CD86 expression while promoting ILT3 upregulation. To assess the influence of AuNPs of different
sizes on LPS-induced surface marker expression, moDCs were cultivated for 48 h with the stated stimuli (5 × 1011 NPs per well, 30 ng mL−1 LPS),
subsequently the cells were harvested and analyzed via flow cytometry. Graphs represent expression in terms of MFI of (A) pro-inflammatory
markers and (B) anti-inflammatory markers on moDCs after stimulation. (C) Dot-plots depicting ILT3 and CD86 expression in control DCs and DCs
treated with LPS, 26 nm AuNPs, or 26 nm AuNPs/LPS. Samples are from of one representative donor. Statistical analysis was performed using
repeated-measures ANOVA combined with the Tukey’s post test. ****P < 0.0001 (three individual experiments, n = 6). Data are shown as mean + SD.
LPS, lipopolysaccharide, MFI, mean fluorescence intensity, NP, nanoparticle.
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3.5 Ultrastructure of the endosomal system and intracellular
localization of NPs
In our attempt to understand the molecular mechanisms
underlying the effects of 26 nm AuNPs, we performed uptake
studies and ultrastructure analysis of our untreated
(Fig. 5A-Aii), LPS-treated (Fig. 5B-Bii), AuNP-treated (Fig. 5Cii
and ESI Fig. 3A, B†) and AuNP/LPS-treated DCs (Fig. 5D-Dii
and ESI Fig. 3C, D†) via transmission electron microscopy
(TEM) after cryofixation. The obtained data show that the
internal structure and, more precisely, the endosomal system
of LPS-activated DCs (Fig. 5B-Bii) differ substantially from
those of untreated control cells (Fig. 5A-Aii).63 In particular,
LPS induced an increase in the size (up to 2 µm) of electron-
lucent late endosomes,64 some of which are characterized by
the presence of intraluminal “buds” representing the early
steps of formation of intraluminal vesicles (ILVs, black aster-
isks),65 which are indicative of the endosomal transition to
multivesicular bodies (MVBs).66 These endosomes were often
accompanied by the appearance of autophagosomes (with
intact cytoplasm) and autophagic compartments (partly
degraded material) in large numbers (white asterisks).64
When DCs were treated with AuNPs instead, a clear uptake/
internalization was visible, both in the absence (Fig. 5C-Cii
and ESI Fig. 3A, B†) or presence of LPS (Fig. 5D-Dii and ESI
Fig. 3C, D†). In all the examined images, AuNPs were always
found enclosed within vesicles, and when the DCs were treated
exclusively with NPs, the ultrastructure of the DC endosomal
compartment was not significantly different from that of
control cells. Interestingly, in this case, NPs were found to be
mainly localized in tubule-vesicular structures of the endo-
somal system (Fig. 5Cii and ESI Fig. 3A, B†) and occasionally
in late endosomes containing ILVs (black arrowhead) (ESI
Fig. 3A†). Overall, the tubule-vesicular structures where com-
posed of both electron-light (low buoyant density) and elec-
tron-dense (high buoyant density) vesicles, with the latter
resembling classic lysosomes.67
In contrast, when DCs were co-exposed to LPS and AuNPs
(Fig. 5D-Dii), we observed dramatic changes in cell ultrastruc-
ture and NP localization in comparison to both LPS-treated
and AuNP-treated DCs.
In the doubly treated cells, there was reduced formation of
large electron-lucent late endosomes, and the NPs were found
to be mainly segregated within autophagic compartments.
Interestingly, only the combination treatment promoted the
formation of multilamellar cisternae organized in stacks
(black stars) (Fig. 5Dii) or U-shaped invaginated vesicles
observed in cross-section (white arrowheads) (Fig. 5Dii and ESI
Fig. 3C, D†) resembling the E class compartments described
by Russel et al. and other authors, which are considered a
form of “stressed” MVBs.65,68–70
The formation of class E compartments and “stressed” mul-
tivesicular bodies is strongly dependent on the activity of the
ESCRT machinery. When ESCRT is dysfunctional, endosomes
and MVBs stop their correct maturation process, do not
produce ILVs, become “frustrated” and cluster to form class E
compartments.68,69,71 The ESCRT machinery plays a role not
only in MVB maturation, but also in different steps of the
autophagic pathway. In fact, the depletion of ESCRT proteins
in cells is commonly associated with the accumulation of
autophagosomes, similar to what we observed in our double-
treated samples.72 Interestingly, AuNPs were shown by
Ma et al. to be able to block autophagy and alter the activity
of the endosomal compartment by increasing the internal pH
of these vesicles and de facto blocking their fusion with lyso-
somes.73 In line with these findings, ESCRT components
have been found in fungi to be part of a pH-sensing
complex which, under alkaline conditions, changes its local-
ization from the endosomal compartment to the plasma
membrane,74 suggesting that pH changes might indeed play
a crucial role in the functionality of the DC endocytic
compartment.
This altered ultrastructural phenotype might partially
explain our finding at the cytokine level. In fact, LPS signaling
is known to rely on two different pathways: the MyD88-depen-
dent cytosolic pathway, and the TRAF-TRIF-dependent
pathway, which relies on receptor endocytosis.4,66,75 Once acti-
vated, both pathways promote the expression of several genes
linked to inflammation. However, while it has been reported
that TNF-α and IL-6 are mainly regulated by MyD88, IL-12
secretion depends on signaling along both pathways,
suggesting that its production might be affected by NP-
mediated changes in receptor endocytosis and trafficking
toward different endocytic compartments such as the endo-
somes or MVBs.66,76–78 Additionally, it has been suggested by
Gangloff that endosomal pH and curvature (which is size-
dependent) may also play a role in the capacity of TLR4 to
recruit TRAM and activate the downstream signaling
pathways.75
Therefore, we propose that deviations in the endocytic
pathway may partially explain the observed effect of AuNPs on
DC activation; however, further studies are needed to confirm
this hypothesis.
3.6 26 nm-treated DCs are less proficient at promoting Th1
activation
Upon microbial infection, DCs quickly initiate adaptive
immune responses by activating T lymphocytes. For this
reason, it is important to assess whether the changes we
detected in the DC phenotype, including the expression of
surface molecules, cytokine secretion, formation of endocytic
structures and intracellular localization of AuNPs, affect the
DC’s ability to induce T-cell activation. A well-accepted model
for studying such aspects is the allogeneic co-culture system.
In this study, we first pre-treated moDCs for 48 h and then
assessed their stimulatory capacity by co-culturing them with
allogeneic CD4+ Th-cells for 6 days (Fig. 6A). During this
period, DCs provide important signals to Th cells, which
instruct the latter to secrete cytokines indicative of their
specific function.
To confirm the quality of the APCs used for the co-culture
experiment, the activation state of moDCs was fully character-
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Fig. 5 AuNP intracellular localization. To assess if 26 nm AuNPs are phagocytosed by DCs and if they can change the cellular phenotype at the
ultrastructural level, moDCs were treated with the following stimuli and subsequently prepared for TEM inspection. (A-Aii) Untreated control, (B-Bii)
LPS control; (C-Cii) 26 nm AuNPs; (D-Dii) 26 nm AuNPs + LPS. Black asterisks, endosomes; white asterisks, autophagic structures; black star, class
E-like compartment; white arrowheads, “frustrated” MVBs.
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ized by flow cytometry and enzyme-linked immunosorbent
assay (ELISA) prior to co-incubation with T cells (ESI Fig. 4†).
As mentioned above, LPS-stimulated moDCs would be
expected to induce a specific T-cell subpopulation known as
Th1 cells, which mainly secrete IFN-γ and IFN-γ-related
factors.11,79 Consistent with this, LPS-treated moDCs promoted
the release of IFN-γ as well as the IFN-γ-inducible protein
CXCL10 in corresponding Th cells (Fig. 6B). However, the pro-
duction of these factors was significantly lower in Th cells co-
cultured with 26 nm AuNP-treated LPS-stimulated DCs,
whereas other cytokines which are not associated with Th1
activation (e.g., TNF-α and IL-17) were not affected by 26 nm
AuNPs.
In fact, the secretion of IL-27 by DCs is of crucial impor-
tance for the initial commitment of naïve T cells to the Th1
lineage, because this cytokine is able to promote the induction
of the Th1-specific transcription profile, which is subsequently
stabilized by sustained IL-12 signaling.32,47–50,80 Since IL-27
was significantly downregulated by 26 nm AuNPs (Fig. 3B) and
the IL-27/IL-12-induced transcription profile is also directly
Fig. 6 26 nm AuNPs downregulate the expression of Th1-related cytokines. (A) To assess the influence of 26 nm AuNPs on the ability of moDCs to
induce T-cell polarization, especially toward the Th1 phenotype, pre-treated moDCs (A1) were co-cultured with allogenic CD4+ T cells, obtained via
magnetic cell separation (A2), for 6 days (A3). Afterwards, supernatants were analyzed by ELISA or LegendPLEX to investigate the secretion of
Th-specific soluble mediators, which are shown in (B). Statistical analysis was performed using repeated-measures ANOVA combined with the
Tukey’s post test (five individual experiments, n ≥ 8). Data are shown as mean + SD. *P < 0.05. AuNP, gold nanoparticle; LPS, lipopolysaccharide; NP,
nanoparticle; n.s., not significant; PBMC, peripheral blood mononuclear cell; Th, T helper cell.
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responsible for the secretion of IFN-γ in Th1 cells, it was not
surprising to find IFN-γ significantly reduced in T cells incu-
bated with LPS/AuNP-treated DCs. In accordance with this, we
also observed a lower secretion of the IFN-γ-dependent chemo-
kine CXCL10, which is known to attract many cell types to
sites of infection.79
Because Th1 cells and their lead cytokine IFN-γ play a
crucial role in macrophage activation and the recruitment of
cytotoxic cells, the observed loss of Th1 cells might have a
negative effect on both pathogen clearance and elimination of
cancerous cells.81–85 However, Th1 cells also seem to be
involved in the pathogenesis of autoimmune diseases such as
Fig. 7 26 nm AuNPs downregulate total numbers of TCMc and Th1 cells and T-cell proliferation. To assess the activity of 26 nm AuNPs in a more
realistic model, human PBMCs were incubated, after resting, for 6 days with the stated stimuli (5 × 1011 NPs per well, 30 ng mL−1 LPS), and sub-
sequently the supernatants were analyzed via ELISA and the cells were analyzed via flow cytometry (two individual experiments, n = 4). (A) Graphic
summary of the protocol. (B) Representative dot plot depicting the distribution of the T cells within the different CD4+ T cell populations (Naïve,
Effector, TEMc, TCMc) upon PBMC stimulation with 26 nm AuNPs ± LPS. Untreated PBMCs serve as a control. Graphs showing (C) total memory
(TCMc and TEMc), (D) total Th1, (E) total proliferating CD4+, and (F) proliferating TCMc and Th1 cells expressed in terms of cells per µL. (G) IL-27
secretion from PBMCs. Statistical analysis was performed using repeated-measures ANOVA combined with the Tukey’s post test. *P < 0.05; **P <
0.005. Data are shown as mean + SD. DC, dendritic cell; LPS, lipopolysaccharide; NP, nanoparticle; PBMC, peripheral blood mononuclear cell;
TCMc, T central memory cell; TEMc, T effector memory cell; Prolif. proliferating.
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rheumatoid arthritis,86 which, interestingly, was treated in the
past using gold-based therapeutics. This suggests that the
observed effects of AuNPs on Th1 differentiation might be
advantageous in the presence of autoimmune diseases, but
potentially harmful in the context of pathogen clearance.
Our observation that AuNPs do not alter the maturation or
activation of DCs in the absence of a concurrent microbial
stimulus is consistent with a previous study by Malachin et al.,
who showed that silica NPs (SiNPs) are able to potentiate the
ability of DCs to activate T cells in response to PAMPs, while
SiNPs alone were unable to activate DCs, unless administered
in combination with microbial components.87 Taken together,
these studies further support the importance of investigating
NP immunomodulatory properties during ongoing immune
responses and not only under homeostatic conditions.
3.7 26 nm AuNPs affect Th1 and TCMc numbers and
proliferation
When NPs are used for medical applications, they are often
injected intravenously into the bloodstream, where they come
into contact with a pool of immune cells called peripheral
blood mononuclear cells (PBMCs). Within this pool, both DCs
and T cells are present; therefore, blood-derived PBMCs are
considered a good model to investigate the effects of NMs on
homologous cell cultures.33 Here, we first extracted human
PBMCs from the blood of healthy donors, and incubated them
for 6 days in the presence of the respective stimuli (26 nm
AuNPs, LPS, and LPS plus 26 nm AuNPs). Finally, we assessed
the effects of LPS and 26 nm AuNPs on the activation of both
Th1 and memory cells via flow cytometry (Fig. 7A) using an
advanced 13-color flow cytometry panel (the gating strategy is
summarized in ESI Fig. 5†).
In human blood, we find mainly two types of memory cells:
central memory T cells (TCMc) and effector memory T cells
(TEMc).33 These populations can be distinguished based on
the expression of distinct homing receptors which grant them
different migration capacities. TCMc express CD197, which
allows their recruitment to lymphatic tissues, whereas TEMc
express mainly markers that direct them to the periphery.
Memory cells do not express the surface marker CD45RA and
therefore can be easily distinguished via flow cytometry from
CD45RA+ naïve and effector cells.88
As shown in Fig. 7B, by using these markers, we could
demonstrate that memory T cells (including TCMc and TEMc)
represent the majority of the CD4+ Th cell populations in
PBMCs,33 with TCMc being the most abundant subset. Upon
treatment, memory cells responded differently to stimulation.
We observed an increase in the total number of TCMc, but not
of TEMc, in LPS-treated samples. Interestingly, this expansion
was significantly hampered by 26 nm AuNPs in TCMc, while
there was no clear effect on LPS-stimulated TEMc (Fig. 7C).
We then investigated the amount of Th1 cells present in
our samples, as they are the subset most responsive to LPS
and other bacterial products. As shown in Fig. 7D, 26 nm
AuNPs caused a decrease in LPS-dependent cell expansion, sig-
nificantly lowering the total number of Th1 cells. A reduced
number of cells is often linked to limited proliferation capacity
in the tested subpopulations. We therefore labeled our
samples with antibodies directed against the proliferation
marker Ki-67 and found that LPS-dependent proliferation of
total, TCMc and Th1 CD4+ lymphocytes was indeed signifi-
cantly reduced by 26 nm AuNPs (Fig. 7E and F).
Several soluble mediators, such as IL-27, are known to regu-
late the ability of these cells to proliferate. Thus, we tested our
cell supernatant and found a positive correlation between the
loss of proliferative potential and reduced IL-27 secretion
(Fig. 7G). This is of particular importance because this cyto-
kine also plays a crucial role in Th1 differentiation.89,90
Taken together, these experiment on autologous cells
further support the findings generated in the allogeneic co-
culture on Th1 activation both in terms of number and prolif-
erative potential of this population. Additionally, utilizing
flow cytometry, we proved that the presence of AuNPs dimin-
ished not only Th1 cells but also the ability of TCMc to pro-
liferate in response to LPS stimulation. This fact may be
linked to the reduced costimulatory capacity of DCs character-
ized by both the upregulation of ILT3, which promotes T-cell
anergy,61 and the attenuated expression of CD86 as well as
the reduced secretion of IL-27 and IL-12. Interestingly, only
central and not effector memory cells reacted to LPS and
were consequently affected by AuNPs. This fact might depend
on several differences that characterize these two subsets. For
example: (1) TCMc are more prone to proliferate and might
therefore be more sensitive to reduced production of IL-27;
(2) TCMc seem to be characterized by a lower activation
threshold than TEMc, which might make them more sensi-
tive to LPS stimulation; and finally, (3) TCMc tend to interact
more with professional APCs in comparison to TEMc, and
therefore might be more impacted by the presence of tDCs.8
These results suggest that AuNPs negatively affect not only
Th1 functions, but also the activation and proliferation of
lymphocytes within the central memory compartment, poten-
tially affecting the outcome of immune responses in the long
term.
4. Conclusions
Here we provided experimental evidence to show that, in the
absence of pro-inflammatory stimuli, AuNPs of different sizes
can be considered to be immunologically safe, since they show
neither immunomodulatory properties nor the ability to sig-
nificantly affect, upon internalization, the ultrastructure of
DCs up to a concentration of 5 × 1011 NPs per well. However,
when 26 nm AuNPs (but not smaller ones) are combined with
LPS, they can direct DCs toward a tolerogenic-like phenotype
(CD86low, IL-12low, IL-27low, ILT3high, class E compartments+),
which is less proficient in promoting LPS-dependent Th1 acti-
vation and TCMc proliferation, both in allogeneic co-culture
systems and in autologous PBMC culture settings. We con-
clude that especially under pro-inflammatory conditions,
26 nm AuNPs may have immunomodulatory capacities. For
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further studies, we would therefore recommend investigating
the effects of NMs in both non-activated as well as activated
immune cells to better understand their immunomodulatory
functions and to predict potential effects of NMs on ongoing
immune responses.
Taken together, these findings further support the idea that
AuNPs are safe under homeostatic conditions; however, par-
ticular care should be taken when deploying them in the
course of ongoing immune responses.
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